Finding medication-caused problems when older adults arrive at the emergency department
Official title: Identification of Iatrogenic Drug Events Upon Admission to the Adult Emergency Departments
Run by University Hospital, Strasbourg, France · NCT07333131 · Data updated 2026-11-12
This project uses a pharmacist checklist (AT HARM 10) to see if it can find medication-related harms in patients over 65 who come to the Hautepierre emergency department in Strasbourg.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 66 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | University Hospital, Strasbourg, France Academic / other |
| Locations | 1 site (Strasbourg) |
| Status | Recruiting |
| Started | July 9, 2025 |
| Main results expected | May 2026 |
| Study ends | May 9, 2026 |
| Registry record updated | January 12, 2026 |
| Trial ID | NCT07333131 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are patients aged over 65 who present to the Hautepierre emergency department with a Von Korff score above 7 and who have not objected to reuse of their medical data.
✕Probably not a fit
Patients under 65, people treated outside the participating emergency department, or those who have opted out of data reuse are unlikely to benefit from this program.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is an observational program in which clinical pharmacists apply the AT HARM 10 checklist to identify possible iatrogenic drug events among older adults presenting to the emergency department. Patients included are over 65, treated at the Hautepierre/CHU de Strasbourg emergency department, and have a Von Korff prioritization score above 7. The approach relies on a multidisciplinary team and an established detection tool that has been validated for use by pharmacists and pharmacy students. Data are used for clinical pharmacy activity to adapt treatment and are included only for patients who have not objected to reuse of their records for research.
Why it matters
Potential benefit: If successful, the work could help emergency teams detect medication-related admissions sooner and guide changes that reduce harmful readmissions.
How similar studies have gone: The AT HARM 10 checklist has been validated for use by pharmacists and pharmacy students, though evidence of broad impact on readmission rates is still limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult patient (\> 65 years old) * Treated in the emergency department of Hautepierre Hospital * Presenting a prioritization score \> 7 according to the Von Korff score * Subject (and their legal representative, if applicable) not objecting to the reuse of their data for scientific research purposes. Exclusion Criteria: \- Presence of a written objection in the patient's medical file (and/or that of their legal representative, if applicable) to the reuse of their data for scientific research purposes
Where it's running
-
Service de Pharmacie - Stérilisation - CHU de Strasbourg - France
Strasbourg, France Recruiting
Study contacts
- Study coordinator: Julia WALTHER, PharmD
- Email: julia.walther@chru-strasbourg.fr
- Phone: 33 3 88 12 78 18
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Patient-specific biomechanical modeling of incisional hernias with AI and finite element analysis
Researchers will test a personalized computer model of the abdominal wall for adults with incisional hernias using anonymized CT data and AI to see how the hernia shapes relate to tissue mechanics.
-
Menin inhibitors in pediatric relapsed or refractory acute leukemia
This study looks at kids with relapsed or treatment-resistant acute leukemia who have specific genetic changes and are treated with menin inhibitors to see how they fare.
-
Long-Term Epilepsy Outcomes in Children After Perinatal Stroke
This study looks at how epilepsy progresses in kids who had a stroke before 28 days old to see how their seizures and syndromes evolve over time.
-
Predictors of Success and Failure of v-NOTES Hysterectomy for Large Uteri
This study looks at which factors predict whether a v-NOTES hysterectomy for large uteri will be completed without needing to switch to another surgical approach.
-
Prehospital end-of-life care: how professionals use a comfort care booklet in Strasbourg
This study tests how emergency crew members in Strasbourg use a comfort care booklet when caring for patients at end of life, and what they think about it.
-
Toxicity of intensive first-line treatment for adult Burkitt lymphoma
This study looks back at adult Burkitt lymphoma patients treated with very aggressive first-line chemotherapy to see how toxic the treatment is and what their long-term outcomes were.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.